Trailing-twelve-month (TTM) revenue is $4.20 Million with a year-over-year growth of (20.95%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,397,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $1,367,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-12 |
| Q1 FY2026Period ended 2026-03-31 | $1,028,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-15 |
| Q2 FY2026Period ended 2026-06-30 | $411,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-14 |
| TTM revenue | $4,203,000 |
Current P/S: $10,735,587 market capitalization ÷ $4,203,000 TTM revenue = 2.55x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:14:40.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $411000.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:16:21.330Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:16:21.330Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
$4.20M
$4.20 Million
(20.95%)
vs. $5.32M a year ago (TTM)
+17.60%
3 Year compound annual growth rate
1 Year
(20.95%)
3 Year
+17.60%
5 Year
N/A
10 Year
(9.65%)
15 Year
(5.11%)
20 Year
+1.28%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $5.21M | ($611,000) | (10.49%) |
| 2024 | $5.82M | +$911,000 | +18.54% |
| 2023 | $4.91M | +$4.69M | +2093.30% |
| 2022 | $224,000 | ($79,000) | (26.07%) |
| 2020 | $303,000 | ($6.70M) | (95.67%) |
| 2019 |
TTM Growth
(20.95%)
3-Year CAGR
+17.60%
5-Year CAGR
N/A
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
| $7.00M |
| +$4.01M |
| +134.60% |
| 2018 | $2.98M | ($3.43M) | (53.47%) |
| 2017 | $6.41M | ($4.97M) | (43.66%) |
| 2016 | $11.38M | ($279,000) | (2.39%) |
| 2015 | $11.66M | +$4.06M | +53.45% |
